Maryland

FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity

SILVER SPRING, Md., July 13, 2018 /PRNewswire-USNewswire/ -- The Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products containing the active…
Continue Reading »
Maryland

Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA’s efforts to advance long-term solutions to prevent shortages

SILVER SPRING, Md., July 12, 2018 /PRNewswire-USNewswire/ -- We've seen the number of new drug shortages steadily decline since a peak in 2011 owing to the work of the FDA,…
Continue Reading »